Denali Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	90.96	174.96	127.11	218.04	293.48	507.14
Short-Term Investments	757.24	657.37	907.41	1,118	571.93	962.55
Cash & Short-Term Investments	848.2	832.33	1,035	1,336	865.41	1,470
Cash Growth	1.39%	-19.54%	-22.58%	54.40%	-41.12%	253.84%
Accounts Receivable	-	2.17	3.42	9.28	-	-
Other Receivables	1.9	-	-	-	1.23	5.67
Receivables	1.9	2.17	3.42	9.28	1.23	5.67
Prepaid Expenses	32.49	29.93	26.21	26.82	30.6	20.28
Total Current Assets	882.6	864.44	1,064	1,372	897.23	1,496
Property, Plant & Equipment	123.21	125.63	71.64	74.52	69.61	73.46
Long-Term Investments	39.7	374.37	-	-	425.45	32.7
Other Long-Term Assets	10.11	9.74	18.14	13.4	11.87	2.46
Total Assets	1,056	1,374	1,154	1,460	1,404	1,604
Accounts Payable	6.75	11.14	9.48	2.79	4.78	1.07
Accrued Expenses	51.58	64.91	61.24	59.37	47.71	42.46
Current Portion of Leases	9.24	12.03	7.26	7.32	5.45	4.69
Current Unearned Revenue	-	-	-	290.05	320.3	23.48
Other Current Liabilities	22.58	14.13	-	4.39	-	-
Total Current Liabilities	90.15	102.21	77.98	363.92	378.25	71.7
Long-Term Leases	35.24	42.29	44.98	53.03	58.55	64.18
Long-Term Unearned Revenue	-	-	-	0.48	4.69	317.17
Other Long-Term Liabilities	4.04	-	-	0.38	0.38	0.7
Total Liabilities	129.42	144.5	122.96	417.81	441.87	453.75
Common Stock	1.79	1.77	1.71	1.69	1.55	1.53
Additional Paid-In Capital	2,846	2,765	2,145	2,019	1,608	1,504
Retained Earnings	-1,923	-1,539	-1,116	-970.99	-645	-354.42
Comprehensive Income & Other	1.1	2.02	0.64	-6.89	-2.5	-0.25
Total Common Equity	926.2	1,230	1,031	1,042	962.29	1,151
Shareholders' Equity	926.2	1,230	1,031	1,042	962.29	1,151
Total Liabilities & Equity	1,056	1,374	1,154	1,460	1,404	1,604
Total Debt	44.48	54.32	52.24	60.35	64.01	68.87
Net Cash (Debt)	828.43	1,137	982.27	1,276	1,227	1,434
Net Cash Growth	-32.62%	15.79%	-23.01%	4.00%	-14.42%	274.57%
Net Cash Per Share	4.84	6.92	7.15	10.16	10.10	12.72
Filing Date Shares Outstanding	146.66	145.22	139.16	136.68	122.83	120.98
Total Common Shares Outstanding	146.63	144.22	138.39	135.97	122.28	120.53
Working Capital	792.45	762.23	986.16	1,008	518.99	1,424
Book Value Per Share	6.32	8.53	7.45	7.67	7.87	9.55
Tangible Book Value	926.2	1,230	1,031	1,042	962.29	1,151
Tangible Book Value Per Share	6.32	8.53	7.45	7.67	7.87	9.55
Machinery	-	60.37	50.35	37.6	32.97	26.91
Leasehold Improvements	-	46.91	41.24	43.7	35.24	34.74

Source: S&P Global Market Intelligence. Standard template. Financial Sources.